You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer

 

Online download statistics by month:

Online download statistics by month: January 2022 to February 2026

AbstractFullPdf
Jan 202236637375
Feb 2022300312104
Mar 202223824389
Apr 202219120375
May 202217819483
Jun 202217518770
Jul 202215315958
Aug 202217217861
Sep 202216416672
Oct 202216016571
Nov 202213713959
Dec 202210610643
Jan 202310410631
Feb 202311611640
Mar 202312513182
Apr 202310110288
May 2023959661
Jun 2023616227
Jul 2023818138
Aug 2023686927
Sep 2023676727
Oct 2023687042
Nov 2023737529
Dec 2023818237
Jan 2024444535
Feb 2024707042
Mar 202413213267
Apr 202410410658
May 202411411555
Jun 202410810952
Jul 2024868739
Aug 2024848639
Sep 2024858539
Oct 2024818338
Nov 2024737435
Dec 20249910150
Jan 2025494933
Feb 2025626241
Mar 2025747551
Apr 202510810972
May 2025757556
Jun 2025484833
Jul 2025110
Nov 2025111
Feb 2026110
Total487949962225